Frontiers in Cardiovascular Medicine | Cardiovascular Metabolism

Review

Published on 11 Oct 2024

Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective

in Cardiovascular Metabolism

Matteo Antonio Russo
Matteo Puccetti
Claudio Costantini
Stefano Giovagnoli
Maurizio Ricci
Enrico Garaci
Luigina Romani

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1411306

1,762 views

Review

Published on 01 Oct 2024

Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress

in Cardiovascular Metabolism

Erika T. Minetti
Naomi M. Hamburg
Reiko Matsui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1469492

3,157 views
3 citations

Review

Published on 22 Aug 2024

Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics

in Cardiovascular Metabolism

Yan Sun
Frank A. Dinenno
Peiyang Tang
Maria I. Kontaridis

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1445739

1,885 views
3 citations

Original Research

Published on 25 Jul 2024

Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study

in Cardiovascular Metabolism

Weitao Wang
Jingwen Qiao
Zhaoyin Su
Hui Wei
Jincan Wu
Yatao Liu
Rubing Lin
Nerich Michael

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1410006

1,665 views

Original Research

Published on 18 Jul 2024

Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia

in Cardiovascular Metabolism

Julieta Danira Morales-Portano
Rafael Trujillo-Cortés
Bricia Margarita Roa-Martínez
Rebeca Pérez-Cabeza de Vaca
Silvia García
Paul Mondragón-Terán
Juan A. Suárez-Cuenca

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417044

1,518 views

Editorial

Published on 17 Jul 2024

Editorial: New discoveries on calcium handling in cardiovascular pathology

in Cardiovascular Metabolism

Andreas Rinne
Jens Kockskämper
Florentina Pluteanu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1461311

906 views

Original Research

Published on 15 Jul 2024

The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARIα

in Cardiovascular Metabolism

Theresa Gissibl
Laura Stengel
Daniel Tarnowski
Lars S. Maier
Stefan Wagner
Anna-Lena Feder
Can Martin Sag

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1379930

1,372 views

Mini Review

Published on 26 Jun 2024

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

in Cardiovascular Metabolism

Ludmila Müller
Svetlana Di Benedetto

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1384996

3,632 views
3 citations

Original Research

Published on 25 Jun 2024

Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

in Cardiovascular Metabolism

Maxime Nguyen
Alain Putot
David Masson
Yves Cottin
Thomas Gautier
Laura Tribouillard
Anne-Laure Rérole
Pierre-Grégoire Guinot
Maud Maza
Jean-Paul Pais de Barros

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1419001

1,020 views

Original Research

Published on 10 Jun 2024

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

in Cardiovascular Metabolism

Ying Wang
Carolin Ertl
Christina Schmitt
Linda Hammann
Rafaela Kramer
Ulrich Grabmaier
Florian Schöberl
David Anz
Ignazio Piseddu
Giulia Pesch

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1408586

3,273 views
3 citations

Editorial

Published on 31 May 2024

Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies

in Cardiovascular Metabolism

F. Bonacina
D. Della-Morte

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1435850

785 views

Review

Published on 31 May 2024

The role of the kynurenine pathway in cardiovascular disease

in Cardiovascular Metabolism

Yuehang Yang
Xing Liu
Xinyi Liu
Chiyang Xie
Jiawei Shi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1406856

4,373 views
8 citations

Original Research

Published on 09 May 2024

Evaluation of bi-directional causal association between obstructive sleep apnoea syndrome and diabetic microangiopathy: a Mendelian randomization study

in Cardiovascular Metabolism

Qianqian Liu
Xingyu Chang
Rongna Lian
Qi Chen
Jialei Wang
Songbo Fu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1340602

3,284 views
1 citation

Mini Review

Published on 25 Mar 2024

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

in Cardiovascular Metabolism

Yue Zeng
Yilang Li
Wenyue Jiang
Ning Hou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1375400

3,981 views
6 citations

Review

Published on 11 Mar 2024

Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases

in Cardiovascular Metabolism

Jia Wang
Wei Guo
Qiang Wang
Yongjian Yang
Xiongshan Sun

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1364604

4,060 views
2 citations

Brief Research Report

Published on 06 Mar 2024

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health

in Cardiovascular Metabolism

Eva Harlacher
Corinna Schulte
Sonja Vondenhoff
Philippe Schmitt-Kopplin
Philippe Diederich
Christian Hemmers
Julia Moellmann
Julia Wollenhaupt
Rogier Veltrop
Erik Biessen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1346475

2,559 views

Navigation group

Articles

Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective

Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress

Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics

Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study

Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia

Editorial: New discoveries on calcium handling in cardiovascular pathology

The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARIα

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies

The role of the kynurenine pathway in cardiovascular disease

Evaluation of bi-directional causal association between obstructive sleep apnoea syndrome and diabetic microangiopathy: a Mendelian randomization study

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health